75
16
Growth Score 75 in past quarter
-10 pts
Heat Score 16 in past quarter
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
569317
Cantoni Therapeutics is committed to finding and creating the greatest small molecule inhibitors available.
- Annegret Aa: CEO & Executive DirectorPast Role: Ermium Therapeutics, CSO & CDO
- Nathaniel Martin: Scientific Advisor & Co-Founder
About the Company
The mission of Cantoni Therapeutics is to find and create small molecule inhibitors of NNMT, a metabolic enzyme that is abundantly expressed in metabolic tissues such as muscle, adipose tissue, and the liver.